Phenanthroline

Phenanthroline

SCHEMBL29367240

[Ru].c1cnc2c(c1)ccc1cccnc12.c1cnc2c(c1)ccc1cccnc12.c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.94
CCR8 P51685 5/20 0.94
LMNA P02545 4/20 0.94
CCR5 P51681 3/20 0.94
KDM4E B2RXH2 3/20 0.94
MMP2 P08253 2/20 0.94
TSHR P16473 2/20 0.94
MAPT P10636 2/20 0.94
HTT P42858 2/20 0.94
SMN1; SMN2 Q16637 2/20 0.94
TDP1 Q9NUW8 2/20 0.94
GMNN O75496 1/20 0.94
TP53 P04637 1/20 0.94
HSP90AA1 P07900 1/20 0.94
CYP3A4 P08684 1/20 0.94
CYP2D6 P10635 1/20 0.94
MMP9 P14780 1/20 0.94
ALOX15 P16050 1/20 0.94
NFKB1 P19838 1/20 0.94
MMP8 P22894 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthroline SCHEMBL5347299 1.00 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29401908 1.00 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL1681332 1.00 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL7268958 1.00 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL345410 1.00 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL15397666 0.97 CCR1 (0.89) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL1237620 0.97 CCR1 (0.89) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL28911275 0.97 CCR1 (0.89) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL8845760 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29354015 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036575-A Photocatalytic synthesis method of sulfimide ester compound 台州学院 2026-05-15 CN claimed
US-12606649-B2 Process for preparation of polyisobutene derivatives BASF SE (DE) 2026-04-21 US claimed
US-20250296906-A1 METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF BASF SE (DE) 2025-09-25 US claimed
CN-119390627-A Synthesis method of photocatalytic asymmetric thioether compound 中国人民解放军军事科学院防化研究院 2025-02-07 CN claimed
EP-4499596-A1 PHOTOCHEMICAL PROCESS FOR PRODUCING ALCOHOLS Fachhochschule Salzburg GmbH (AT) 2025-02-05 EP claimed
US-20240360344-A1 CHEMICAL-RESISTANT, REACTIVE, PRESSURE-SENSITIVE ADHESIVE TAPE TESA SE (DE) 2024-10-31 US claimed
EP-4455241-A1 CHEMICAL-RESISTANT REACTIVE PRESSURE SENSITIVE ADHESIVE TAPE TESA SE (DE) 2024-10-30 EP claimed
CN-118788392-A Fullerene-organic framework composite material and photocatalytic application thereof 中国科学院化学研究所 2024-10-18 CN claimed
CN-114685331-B Process for producing 1, 2-dithioethane compound 华南理工大学 2024-07-09 CN claimed
CN-118022788-A Preparation method and application of biomass carbon coated heteropolyacid hydrogen salt catalyst 西北大学 2024-05-14 CN claimed
CN-113024423-B Beta-fluoro, beta' -bissulfonylimide substituted ketone compound and preparation method and application thereof 山东领海生物科技有限公司 2023-03-21 CN claimed
CN-115477624-A Preparation method of arylamine compound 南方科技大学 2022-12-16 CN claimed
CN-110895260-B Preparation method and application of Medusa p300 electrochemiluminescence sensor based on DNA nano net 宁波大学 2022-07-15 CN claimed
US-20220169680-A1 CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-06-02 US claimed
WO-2022106263-A1 PROCESS FOR PREPARATION OF POLYISOBUTENE DERIVATIVES BASF SE (DE) 2022-05-27 WO claimed
EP-4001321-A1 PROCESS FOR PREPARATION OF POLYISOBUTENE DERIVATIVES BASF SE (DE) 2022-05-25 EP claimed
EP-3998021-A1 COLORIMETRIC SENSOR FORMULATION AND USE THEREOF The Provost, Fellows, Foundation Scholars and the other members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth, (IE) 2022-05-18 EP claimed
WO-2022053965-A1 NANOPARTICLES TO IMPROVE ANALYTICAL SIGNAL ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2022-03-17 WO claimed
WO-2022053718-A1 METHOD FOR LABELING NUCLEIC ACID CAMBRIDGE ENTERPRISE LIMITED (GB) 2022-03-17 WO claimed
CN-114163313-A Method for selectively synthesizing EZ-stilbene by coupling aryl diazonium salt and cinnamic acid under catalysis of ruthenium 中山大学 2022-03-11 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250296906-A1 METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF ALDH1A2, ADH4, RBP4 CCR1 3972/4885CCR8 3604/4885LMNA 580/4885
US-12606649-B2 Process for preparation of polyisobutene derivatives TCP1, POLD1, VAPA CCR1 3982/4885CCR8 4351/4885LMNA 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.